Biochemical and Metabolic Testing Services

The contract seeks specialized biochemical and metabolic testing services to support the diagnosis of rare metabolic and mitochondrial disorders in undiagnosed patients, with a focus on amino acid profiling, organic acid analysis, and enzyme assays. These analyses are critical for identifying underlying biochemical abnormalities that may not be detectable through standard diagnostic methods, enabling more accurate clinical decision-making and personalized patient care. The work is to be performed at the designated location in Bethesda, Maryland, with a performance timeframe aligned with the federal funding cycle and regulatory requirements for clinical diagnostic laboratories. This subcontract is issued under the National Institutes of Health, Office of Laboratory Animal Welfare, and falls under the NAICS code 621511 for medical and diagnostic laboratories. The opportunity was posted on July 28, 2026, with a response deadline of August 7, 2026, and is part of a broader effort by the Department of Health and Human Services to expand diagnostic capabilities for complex genetic and metabolic conditions. While no specific set-aside provisions are indicated, the subcontractor must possess the technical expertise, validated methodologies, and regulatory compliance necessary to deliver high-confidence results in a clinical research environment.